Panelists discuss how emerging biomarkers like neurofilament light protein, glial fibrillary acidic protein (GFAP), cervical cord atrophy, and phase rim lesions could enable earlier identification of ...

Black women are diagnosed with cervical insufficiency more than any other demographic in the U.S. We should be having more conversations about this.

A successful claim for PIP or ADP is now worth between £29.20 and £187.45 each week in additional financial support and as ...

Discover how atrophic gastritis silently damages stomach tissue while increasing cancer risk, often going undiagnosed for years.

Cervical cancer, the fourth most common cancer among women, often develops silently, making early detection crucial. Symptoms like abnormal bleeding, ...

This so-called cervix-on-a-chip reveals how inflammation and the vaginal microbiome can contribute to premature birth – and identifies a possible treatment to prevent it.

The FDA has approved the Teal Wand, the first at-home cervical cancer screening device, enhancing women's access to vital health care.

At-home cervical cancer screening test gets FDA approval. How it works, availability The Teal Wand is an at-home vaginal sample self-collection device that tests for HPV. The test will first be ...

To get screened for cervical cancer, patients in the United States may no longer need to put their feet in those awkward stirrups, brace for the uncomfortable speculum or even take the time off ...

Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.

Scholar Rock's biologics license application for apitegromab was accepted by the Food and Drug Administration. The late-stage biopharmaceutical company said the regulator will review the ...

The FDA has accepted for Priority Review the BLA for apitegromab for the improvement of motor function in patients with spinal muscular atrophy.